Granulate comprising eslicarbazepine acetate and pharmaceutical composition comprising thereof

The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	dr. Gal Livia, dr. Bajdik Janos, dr. Fekete Pal, Oeszi Zsolt
Format:	Patent
Sprache:	eng ; hun
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	dr. Gal Livia dr. Bajdik Janos dr. Fekete Pal Oeszi Zsolt
description	The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUP1900153A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUP1900153A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUP1900153A13</originalsourceid><addsrcrecordid>eNrjZIhzL0rMK81JLElVSM7PLSjKLM7MS1dILc7JTE4sSkqsSi3IzEtVSExOLQEpScxLUSjISCzKBQqUlgCV5IB15RdnlmTm5yGbUJKRWpSan8bDwJqWmFOcyguluRkU3VxDnD10Uwvy41OLC4Dm5KWWxHuEBhhaGhgYmho7GhoTowYA_uk-PQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Granulate comprising eslicarbazepine acetate and pharmaceutical composition comprising thereof</title><source>esp@cenet</source><creator>dr. Gal Livia ; dr. Bajdik Janos ; dr. Fekete Pal ; Oeszi Zsolt</creator><creatorcontrib>dr. Gal Livia ; dr. Bajdik Janos ; dr. Fekete Pal ; Oeszi Zsolt</creatorcontrib><description>The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.</description><language>eng ; hun</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201130&DB=EPODOC&CC=HU&NR=P1900153A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201130&DB=EPODOC&CC=HU&NR=P1900153A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>dr. Gal Livia</creatorcontrib><creatorcontrib>dr. Bajdik Janos</creatorcontrib><creatorcontrib>dr. Fekete Pal</creatorcontrib><creatorcontrib>Oeszi Zsolt</creatorcontrib><title>Granulate comprising eslicarbazepine acetate and pharmaceutical composition comprising thereof</title><description>The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIhzL0rMK81JLElVSM7PLSjKLM7MS1dILc7JTE4sSkqsSi3IzEtVSExOLQEpScxLUSjISCzKBQqUlgCV5IB15RdnlmTm5yGbUJKRWpSan8bDwJqWmFOcyguluRkU3VxDnD10Uwvy41OLC4Dm5KWWxHuEBhhaGhgYmho7GhoTowYA_uk-PQ</recordid><startdate>20201130</startdate><enddate>20201130</enddate><creator>dr. Gal Livia</creator><creator>dr. Bajdik Janos</creator><creator>dr. Fekete Pal</creator><creator>Oeszi Zsolt</creator><scope>EVB</scope></search><sort><creationdate>20201130</creationdate><title>Granulate comprising eslicarbazepine acetate and pharmaceutical composition comprising thereof</title><author>dr. Gal Livia ; dr. Bajdik Janos ; dr. Fekete Pal ; Oeszi Zsolt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUP1900153A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>dr. Gal Livia</creatorcontrib><creatorcontrib>dr. Bajdik Janos</creatorcontrib><creatorcontrib>dr. Fekete Pal</creatorcontrib><creatorcontrib>Oeszi Zsolt</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>dr. Gal Livia</au><au>dr. Bajdik Janos</au><au>dr. Fekete Pal</au><au>Oeszi Zsolt</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Granulate comprising eslicarbazepine acetate and pharmaceutical composition comprising thereof</title><date>2020-11-30</date><risdate>2020</risdate><abstract>The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; hun
recordid	cdi_epo_espacenet_HUP1900153A1
source	esp@cenet
title	Granulate comprising eslicarbazepine acetate and pharmaceutical composition comprising thereof
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A22%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=dr.%20Gal%20Livia&rft.date=2020-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUP1900153A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true